| abstract |
Described herein are compounds of formula (I), which are novel antagonists for melanin-concentrating hormone (MCH), as well as methods of making such compounds:n n n Formula In n n n n n n n In another aspect, described herein are pharmaceutical compositions comprising said MCH antagonists, as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as overeating, and diabetes. |